154 related articles for article (PubMed ID: 32885692)
21. The success rate of TED upper eyelid retraction reoperations.
Golan S; Rootman DB; Goldberg RA
Orbit; 2016 Dec; 35(6):335-338. PubMed ID: 27560939
[TBL] [Abstract][Full Text] [Related]
22. [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease].
Dintelmann T; Sold J; Grehn F
Ophthalmologe; 2005 Mar; 102(3):247-50. PubMed ID: 15322802
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.
Costa PG; Saraiva FP; Pereira IC; Monteiro ML; Matayoshi S
Eye (Lond); 2009 Apr; 23(4):767-73. PubMed ID: 18535592
[TBL] [Abstract][Full Text] [Related]
24. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease.
Kazim M; Gold KG
Curr Opin Ophthalmol; 2011 Sep; 22(5):391-3. PubMed ID: 21730842
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy.
Ben Simon GJ; Mansury AM; Schwarcz RM; Lee S; McCann JD; Goldberg RA
Ophthalmology; 2005 May; 112(5):923-32. PubMed ID: 15878077
[TBL] [Abstract][Full Text] [Related]
26. Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
Yang J; Hu X; Li Q; Huang RL
J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e485-e488. PubMed ID: 37221639
[TBL] [Abstract][Full Text] [Related]
27. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
Lee JM; Lee H; Park M; Baek S
J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
Yücel OE; Artürk N
Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
[TBL] [Abstract][Full Text] [Related]
29. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease.
Rosenblatt TR; Chiou CA; Yoon MK; Lee NG; Wolkow N; Freitag SK
Orbit; 2024 Jun; 43(3):337-343. PubMed ID: 38466206
[TBL] [Abstract][Full Text] [Related]
30. Safety of onabotulinum toxin a injection to the central upper eyelid and eyebrow regions.
Huang L; Costin BR; Sakolsatayadorn N; Perry JD
Ophthalmic Plast Reconstr Surg; 2014; 30(5):377-80. PubMed ID: 24777259
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients.
Young SM; Kim JH; Kim YD; Karnsiritanont V; Lang SS; Woo KI
Orbit; 2023 Aug; 42(4):389-396. PubMed ID: 36082627
[TBL] [Abstract][Full Text] [Related]
32. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.
Xu D; Liu Y; Xu H; Li H
Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849
[TBL] [Abstract][Full Text] [Related]
33. The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment.
Frueh BR; Nelson CC; Kapustiak JF; Musch DC
Am J Ophthalmol; 1988 Jul; 106(1):45-7. PubMed ID: 3394768
[TBL] [Abstract][Full Text] [Related]
34. Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler.
Mancini R; Khadavi NM; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2011; 27(1):1-3. PubMed ID: 20551854
[TBL] [Abstract][Full Text] [Related]
35. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
Steinsapir KD; Groth MJ; Boxrud CA
Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
[TBL] [Abstract][Full Text] [Related]
36. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method.
Young SM; Kim YD; Lang SS; Woo KI
Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of lower eyelid epiblepharon by injection of botulinum toxin A in patients under two years of age.
Chen CY; Nava-Castaneda A
Nepal J Ophthalmol; 2013; 5(2):177-81. PubMed ID: 24172551
[TBL] [Abstract][Full Text] [Related]
38. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
Arat YO; Yen MT
Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
[TBL] [Abstract][Full Text] [Related]
39. Comparison between hyaluronic acid filler and botulinum toxin type A in the treatment of thyroid upper eyelid retraction.
Hassan Hussien M; Abd El-Wahed Hassan E; El-Haddad NSEM
Ther Adv Ophthalmol; 2020; 12():2515841420979113. PubMed ID: 33447731
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation.
Kohn JC; Rootman DB; Liu W; Goh AS; Hwang CJ; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2014; 30(5):400-4. PubMed ID: 24833450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
